Calcilos 0,25 μg/0,5 μg/1 μg Capsules
PDF Leaflet Revision Date: 7 November 2024
Clinical Summary
Quick overview from the medicine insert
Indication
Management of renal osteodystrophy and related conditions.
Dosage (summary)
Adults: 1 u03bcg daily; Elderly: 0.5 u03bcg daily; Adjust based on response.
Onset of Action / Duration
Onset: 6 hours, Duration: Varies.
Special Populations
- Renal impairment
- Elderly
Pregnancy & Breastfeeding
Contraindicated in pregnancy and breastfeeding.
Key Drug Interactions
- Thiazide diuretics
- Anticonvulsants
- Calcium preparations
Contraindications
- Hypersensitivity to ingredients
- Hypercalcaemia
- Vitamin D intoxication
Common side effects
- Hypercalcaemia
- Pruritus
- Abdominal pain
Counselling Points
- Avoid in pregnancy and breastfeeding
- Monitor calcium levels
- Report symptoms of hypercalcaemia
Serious warnings
- Risk of hypercalcaemia
- Monitor plasma calcium regularly
Important Disclaimer
The Calcilos 0,25 μg/0,5 μg/1 μg Capsules professional information leaflet below is the property of Strides Pharma Sa and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
